Meth Promotes Spread of Virus in HIV-Infected UsersAugust 07, 2006
The investigators found that meth increases expression of a receptor called DC-SIGN, a "virus-attachment factor," allowing more of the virus to invade the immune system.
"This finding shows that using meth is doubly dangerous," said Madhavan P.N. Nair, Ph.D., first author on the study, published in the online version of the Journal of Neuroimmune Pharmacology. The study will appear in print in the September issue of the journal.
"Meth reduces inhibitions, thus increasing the likelihood of risky sexual behavior and the potential to introduce the virus into the body, and at the same time allows more virus to get into the cell," said Nair, professor of medicine and a specialist in immunology in the UB School of Medicine and Biomedical Sciences.
His research centers on dendritic cells, which serve as the first line of defense again pathogens, and two receptors on these cells - HIV binding/attachment receptors (DC-SIGN) and the meth-specific dopamine receptor. Dendritic cells overloaded with virus due to the action of methamphetamine can overwhelm the T cells, the major target of HIV, and disrupt the immune response, promoting HIV infection.
"Now that we have identified the target receptor, we can develop ways to block that receptor and decrease the viral spread," said Nair. "We have to approach this disease from as many different perspectives as possible.
"If we could prevent the upregulation of the meth-specific dopamine receptor by blocking it, we may be able to prevent the interaction of meth with its specific receptors, thereby inhibiting the virus attachment receptor," said Nair.
"Right now, we don't know how the virus-attachment receptor and meth-specific receptors interact with each other, leading to the progression of HIV disease in meth-using HIV-infected subjects. That is the next question we want to answer.
"Since meth mediates its effects through interacting with dopamine receptors present on the cells, and meth increases DC-SIGN, which are the HIV attachment receptors, use of dopamine receptor blockers during HIV infection in meth users could be beneficial therapeutically to reduce HIV infection in these high-risk populations," Nair said.
Additional researchers on the publication, all from the UB Department of Medicine, are Supriya Mahajan, Ph.D., research assistant professor; Donald Sykes, Ph.D., research associate professor; Meghana V. Bapardekar, Ph.D., postdoctoral associate, and Jessica L. Reynolds, Ph.D., research assistant professor.
The University at Buffalo is a premier research-intensive public university, the largest and most comprehensive campus in the State University of New York. The School of Medicine and Biomedical Sciences is one of five schools that constitute UB's Academic Health Center.
University at Buffalo
Related Meth Current Events and Meth News Articles
TSRI scientists find hyped new recreational drug 'flakka' is as addictive as bath salts
Scientists at The Scripps Research Institute (TSRI) have found using animal models that the new recreational drug alpha-PVP ("flakka") seems equivalently potent as a stimulant, and therefore as addictive, as its chemical cousin MDPV ("bath salts").
Meth users face substantially higher risk for getting Parkinson's disease
In addition to incurring serious dental problems, memory loss and other physical and mental issues, methamphetamine users are three times more at risk for getting Parkinson's disease than non-illicit drug users, new research from the University of Utah and Intermountain Healthcare shows.
Laser sniffs out toxic gases from afar
Scientists have developed a way to sniff out tiny amounts of toxic gases -- a whiff of nerve gas, for example, or a hint of a chemical spill -- from up to one kilometer away.
Asteroid impacts on Earth make structurally bizarre diamonds, say ASU scientists
Scientists have argued for half a century about the existence of a form of diamond called lonsdaleite, which is associated with impacts by meteorites and asteroids.
Long-acting Anti-Methamphetamine Antibody Demonstrates Protective Benefits for Meth Addiction Treatment
A recently developed Adeno-Associated Virus (AAV)-based medication has the potential to offer substantial protective effects for patients attempting to cease methamphetamine use.
'Swingers' multiple drug use heightens risk of sexually transmitted diseases
These so called 'swingers' need to be offered more tailored interventions by sexual health services to help encourage safer sexual practices and prevent the spread of sexually transmitted infections (STIs).
CU Denver study shows zoning regulations impact where marijuana dispensaries can locate
Municipal zoning regulations may push marijuana dispensaries into low income, minority areas, according to a study just released by the University of Colorado Denver.
A tricky balancing act: Antibiotics versus the gut microbiota
Antibiotics are valuable, potentially life-saving tools that have significantly reduced human morbidity and mortality. Unfortunately, antibiotics may also have unintended consequences from their off-target effects that may increase the risk of many long-term conditions.
Stress steroid mediated withdrawal anxiety in dependent rats reversible by flumazenil
SUNY Downstate Medical Center announced today that Sheryl Smith, PhD, professor of physiology and pharmacology, has published new findings demonstrating a reproducible pathology that may help shed light on anxiety and mood volatility in methamphetamine dependence.
Scripps Research Institute Study Suggests Possibility of Selectively Erasing Unwanted Memories
The human brain is exquisitely adept at linking seemingly random details into a cohesive memory that can trigger myriad associations-some good, some not so good.
More Meth Current Events and Meth News Articles